
Jay Precision Pharmaceuticals Private Limited
Manufactures and sells respiratory devices and pharmaceutical products for various uses.
Manufactures and sells respiratory devices and pharmaceutical products for various uses.
Jay Precision Pharmaceuticals Private Limited (JPPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 01 August 2012 and has a history of 12 years and seven months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.50 Cr and a paid-up capital of Rs 4.01 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Jay Precision Pharmaceuticals Private Limited India is Mandar Kurghode as COMPANY SECRETARY. Dinesh Jain, Amrita Nautiyal, Xerxes Rao, and Four other members serve as directors at the Company.
Mumbai, Maharashtra, India
+91-XXXXXXXXXX
U33111MH2012PTC234037
234037
Private Limited Indian Non-Government Company
01 Aug 2012
09 Sep 2024
31 Mar 2024
Unlisted
Roc Mumbai
Name | Designation | Appointment Date | Status |
---|---|---|---|
Xerxes Rao ![]() | Managing Director | 01-Aug-2012 | Current |
Mandar Kurghode | Company Secretary | 24-Aug-2021 | Current |
Name | Designation | Appointment Date | Status |
---|---|---|---|
Zubin Rao ![]() | Director | 02-Jan-2020 | Current |
Rajeev Sinha ![]() | Director | 05-Jun-2024 | Current |
Dinesh Jain ![]() | Director | 01-Apr-2022 | Current |
Amrita Nautiyal ![]() | Director | 10-Sep-2019 | Current |
Chandrashekhar Iyer ![]() | Director | 10-Sep-2019 | Current |
Achin Gupta ![]() | Director | 03-May-2022 | Current |
Jay Precision Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 35.67% increase. The company also saw a substantial improvement in profitability, with a 24.37% increase in profit. The company's net worth moved up by a moderate rise of 3.8%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2023, Jay Precision Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Amrita Nautiyal is a mutual person
Dinesh Jain is a mutual person
Amrita Nautiyal is a mutual person
Dinesh Jain is a mutual person
Dinesh Jain and Rajeev Sinha are mutual person
Dinesh Jain and Achin Gupta are mutual person
There are no open charges registered against the company as per our records.
Jay Precision Pharmaceuticals has a workforce of 438 employees as of Jun 19, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Jay Precision Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jay Precision Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Jay Precision Pharmaceuticals Private Limited last Annual general meeting of members was held on 09 Sep 2024 as per latest MCA records.
Rajeev Kumar Sinha was appointed as a Director was appointed as a Director on 05 Jun 2024 & has been associated with this company since 9 months 22 days .
Jay Precision Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Achin Gupta was appointed as a Director was appointed as a Director on 03 May 2022 & has been associated with this company since 2 years 10 months .
Dinesh Ramniranjan Jain was appointed as a Director was appointed as a Director on 01 Apr 2022 & has been associated with this company since 2 years 11 months .
Mandar Kurghode was appointed as a Company Secretary was appointed as a Company Secretary on 24 Aug 2021 & has been associated with this company since 3 years 7 months .
Jay Precision Pharmaceuticals Private Limited was incorporated on 01 Aug 2012.
The authorized share capital of Jay Precision Pharmaceuticals Private Limited is ₹ 4.50 Cr and paid-up capital is ₹ 4.01 Cr.
Currently 8 directors are associated with Jay Precision Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Jay Precision Pharmaceuticals Private Limited is Tower A 1St Floor Peninsula Business Park Ganpatrao Kadam Marg Lower Parel, India, Mumbai, Maharashtra, 400013.
The corporate identification number (CIN) of Jay Precision Pharmaceuticals Private Limited is U33111MH2012PTC234037 and the company number is 234037 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2022, the revenue trend for Jay Precision Pharmaceuticals Private Limited has risen by 35.67%.
As Per 2022 financial reports, 438 employees are currently employed by Jay Precision Pharmaceuticals Private Limited.
The financial reports for the fiscal year 2022 indicates that The net worth of Jay Precision Pharmaceuticals Private Limited has experienced an upsurge of 3.80%.
The most recent Balance Sheet for Jay Precision Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.
SX
GM